#IVTEAM #Intravenous literature: “We report two cases in which a localized M. fortuitum cutaneous infection developed on continuous subcutaneous insulin infusion (CSII) sites during pump therapy.” López Aventín et al (2014).
López Aventín, D., Rubio González, B., Petiti Martín, G., Segura, S., Rodríguez-Peralto, J.L., Riveiro-Falkenbach, E., Puig, J. and Pujol, R.M. (2014) Mycobacterium fortuitum infection in continuous subcutaneous insulin infusion sites. The British Journal of Dermatology. March 3rd. [epub ahead of print].
Mycobacterium fortuitum (M. fortuitum) is an atypical rapidly growing mycobacteria widely distributed in soil, dust and water which can behave as an opportunistic human pathogen.1 Accidental injuries, medical procedures (surgery, injections, and catheters) or medical and paramedical cosmetic procedures are often incriminated as portal of entry for skin and soft-tissue infections caused by this microorganism.2 Herein, we report two cases in which a localized M. fortuitum cutaneous infection developed on continuous subcutaneous insulin infusion (CSII) sites during pump therapy.
Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).
- Guide for intravenous chemotherapy and associated vascular access devices from Macmillan.
- CancerUK IV chemotherapy information.